CliffBio
small molecule

SALONPAS

MENTHOL; METHYL SALICYLATE

Loss of exclusivityJanuary 2030latest FDA-listed patent expiry
CompanyHisamitsu Pharmaceutical →View the full company profile on CliffBio

Drug detail

Brand nameSALONPAS
Active ingredientMENTHOL; METHYL SALICYLATE
Strength3%;10%
Dosage formPATCH
RouteTOPICAL
ModalitySmall molecule
FDA approvalNovember 2012
Marketing statusOTC

Listed patents

PatentExpiresType
8809615January 2030product
9233184August 2027product

More from Hisamitsu Pharmaceutical

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

SALONPAS patent cliff — loss of exclusivity January 2030 | CliffBio